Adoptive immunotherapy with haploidentical KIR-ligand mismatched NK cells for acute myeloblastic leukemia patients

被引：0
|
作者：
Lemoli, Roberto. M. [1 ]
机构：
[1] Univ Genoa, Genoa, Italy
来源：
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION | 2017年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O4.01
引用
下载
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [1] Phase I-II trial of adoptive immunotherapy with haploidentical KIR ligand mismatched natural killer cells in high risk acute myeloblastic leukemia patients
    Curti, A.
    Ruggeri, L.
    D'Addio, A.
    Urbani, E.
    Bontadini, A.
    Fruet, F.
    Giudice, V
    Dan, E.
    MR, Motta
    Rizzi, S.
    Paolini, S.
    Gugliotta, G.
    Conte, R.
    Martinelli, G.
    Velardi, A.
    Baccarani, M.
    RM, Lemoli
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 12 - 13
  • [2] Phase I-II trial of adoptive immunotherapy with haploidentical KIR ligand-mismatched natural killer cells in high risk acute myeloblastic leukemia patients
    Curti, Antonio
    Ruggeri, Loredana
    D'Addio, Alessandra
    Urbani, Elena
    Bontadini, Andrea
    Fruet, Fiorenza
    Giudice, Valeria
    Dan, Elisa
    Motta, Maria Rosa
    Rizzi, Simona
    Paolini, Stefania
    Gugliotta, Gabriele
    Conte, Roberto
    Martinelli, Giovanni
    Velardi, Andrea
    Baccarani, Michele
    Lemoli, Roberto M.
    BLOOD, 2007, 110 (11) : 840A - 841A
  • [3] PHASE I-II TRIAL OF ADOPTIVE IMMUNOTHERAPY WITH HAPLOIDENTICAL KIR LIGAND-MISMATCHED NATURAL KILLER CELLS IN HIGH RISK ACUTE MYELOBLASTIC LEUKEMIA PATIENTS
    Curti, A.
    Ruggeri, L.
    D'Addio, A.
    Urbani, E.
    Bontadini, A.
    Fruet, F.
    Giudice, V
    Dan, E.
    Motta, M. R.
    Rizzi, S.
    Paolini, S.
    Martinelli, G.
    Velardi, A.
    Baccarani, M.
    Lemoli, R. M.
    HAEMATOLOGICA, 2008, 93 : S127 - S127
  • [4] Phase I-II trial of adoptive immunotherapy with haploidentical KIR ligand-mismatched natural killer cells in high-risk acute myeloblastic leukaemia patients
    D'Addio, A.
    Curti, A.
    Ruggeri, L.
    Urbani, E.
    Bontadini, A.
    Fruet, F.
    Giudice, V.
    Dan, E.
    Motta, M. R.
    Rizzi, S.
    Paolini, S.
    Martinelli, G.
    Velardi, A.
    Baccarani, M.
    Lemoli, R. M.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S72 - S72
  • [5] Phase I-II trial of adoptive immunotherapy with haploidentical KIR ligand-mismatched natural killer cells in high-risk acute myeloblastic leukaemia patients
    D'Addio, A.
    Curti, A.
    Ruggeri, L.
    Urbani, E.
    Bontadini, A.
    Fruet, F.
    Giudice, V.
    Dan, E.
    Motta, M. R.
    Rizzi, S.
    Paolini, S.
    Gugliotta, G.
    Conte, R.
    Martinelli, G.
    Velardi, A.
    Baccarani, M.
    Lemoli, R. M.
    BONE MARROW TRANSPLANTATION, 2008, 41 : S160 - S160
  • [6] Adoptive Immunotherapy with Haploidentical Kir Ligand-Mismatched Natural Killer Cells In Elderly High Risk Acute Myeloid Leukemia Patients: Biological and Clinical Results of A Pilot Study.
    Curti, Antonio
    Ruggeri, Loredana
    D'Addio, Alessandra
    Bontadini, Andrea
    Giudice, Valeria
    Dan, Elisa
    Motta, Maria Rosa
    Rizzi, Simonetta
    Trabanelli, Sara
    Urbani, Elena
    Martinelli, Giovanni
    Paolini, Stefania
    Fruet, Fiorenza
    Isidori, Alessandro
    Casadei, Beatrice
    Bandini, Giuseppe
    Baccarani, Michele
    Velardi, Andrea
    Lemoli, Roberto M.
    BLOOD, 2010, 116 (21) : 1740 - 1740
  • [7] Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity
    Pende, Daniela
    Marcenaro, Stefania
    Falco, Michela
    Martini, Stefania
    Bernardo, Maria Ester
    Montagna, Daniela
    Romeo, Elisa
    Cognet, Celine
    Martinetti, Miryam
    Maccario, Rita
    Mingari, Maria Cristina
    Vivier, Eric
    Moretta, Lorenzo
    Locatelli, Franco
    Moretta, Alessandro
    BLOOD, 2009, 113 (13) : 3119 - 3129
  • [8] Immunotherapy with haplo-identical KIR-ligand mismatched natural killer cells in the setting of autologous transplantation.
    Szmania, SM
    Smith, S
    Bennett, G
    Batchu, RB
    Barlogie, B
    Cottler-Fox, MH
    Tricot, G
    van Rhee, F
    BLOOD, 2003, 102 (11) : 399B - 399B
  • [9] IMPACT OF KIR-LIGAND AND KIR-GENE EXPRESSION ON NK CELLS MEDIATED KILLING OF MYELOMA CELLS
    Stuebig, T.
    Hildebrandt, Y.
    Jungk, K.
    Konielski, A.
    Lange, L.
    Binder, T.
    Duske, H.
    Atanackovic, D.
    Fehse, B.
    Eiermann, T.
    Zander, A.
    Kroeger, N.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 308 - 308
  • [10] Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients
    Curti, Antonio
    Ruggeri, Loredana
    D'Addio, Alessandra
    Bontadini, Andrea
    Dan, Elisa
    Motta, Maria Rosa
    Trabanelli, Sara
    Giudice, Valeria
    Urbani, Elena
    Martinelli, Giovanni
    Paolini, Stefania
    Fruet, Fiorenza
    Isidori, Alessandro
    Parisi, Sarah
    Bandini, Giuseppe
    Baccarani, Michele
    Velardi, Andrea
    Lemoli, Roberto M.
    BLOOD, 2011, 118 (12) : 3273 - 3279
12345